In hematuria patients, urinary DNA methylation test showed 89% sensitivity & 88% specificity for high-grade/invasive #BladderCancer. Outperformed NMP22 & cytology @oncoalert.bsky.social @jama.com jamanetwork.com/journals/jam...

#FDA approves neoadjuvant durvalumab w/ gem/cis followed by adjuvant durvalumab after radical cystectomy for MIBC based on NIAGRA study #oncsky #cansky #bladdercancer bit.ly/3DNZceK #blcsm

Zach Klaassen, MD, and @joshmeeks.bsky.social, MD, PhD, discuss the need to move beyond single-arm trials in BCG-unresponsive #BladderCancer treatment, given the current availability of multiple FDA-approved options. bit.ly/44d1n6b

#Lebanon has one of the world’s highest #BladderCancer rates. New study reports 46% of cases are linked to smoking, 8.6% to contaminated water, and 6% to air pollution. Urgent action on tobacco control & environmental reform needed to reduce preventable cancer burden. #Oncology #MENAHealth

Join the University of Birmingham Bladder Cancer Research Centre and the Kings College London & Guys Hospital Transforming cancer OUtcomes through Research (TOUR) team at the Edgbaston Park Hotel & Conference Centre on Friday 28th February 2025. #bladdercancer #cancerresearch

Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI - Andrea Necchi oncodaily.com/science/213051 #BladderCancer #Cancer #Chemotherapy #Immunotherapy #MRI #OncoDaily #Oncology #Radiology #Medicine #Health

New @theaacr.bsky.social Cancer Discovery paper on ecDNA in urothelial carcinoma reveals how ecDNAs: 💡 Drive #BladderCancer evolution 💡 Promote immune evasion 💡 Amplify oncogenes 💡 Fuel tumour heterogeneity 💡 May be a biomarker in urine for non-invasive detection aacrjournals.org/cancerdiscov...

Rapid-fire debates bladder cancer at EAU 2025 - Gianluca Giannarini @giannarini.bsky.social @uroweb.bsky.social oncodaily.com/blog/gianluc... #Cancer #Medicine #Health #BladderCancer #EAU25 #Oncology #OncoDaily

Pros for BCG outlined by Gianluca Giannarini at EAU2025 - Sabine D. Brookman-May @brookmans76.bsky.social @giannarini.bsky.social @uroweb.bsky.social oncodaily.com/blog/sabine-... #Cancer #Medicine #Health #EAU2025 #BladderCancer #Oncology #OncoDaily

Looking for input from people with #bladdercancer Please answer the survey below if you can🙏🏽 @bladdercancer.bsky.social @mcrcnews.bsky.social www.research.net/r/2025NewFaces

Great to see this finally out #bladdercancer ascopubs.org/doi/10.1200/...

Wow! Nanobots - powered by urea - target Bladder Cancer with radionucleotides www.nature.com/articles/s41...

Nice review on Metastatic non-muscle invasive bladder cancer. Great work www.nature.com/articles/s41... .....

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination. ja.ma/4i9ghPC

Comprehensive care is🔑in #BladderCancer Our editorial explores how exercise, nutrition & psychosocial support improve outcomes @paulobergerot.bsky.social & cols Editorial acsjournals.onlinelibrary.wiley.com/doi/10.1002/... Paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/...

🦷 New Research: Higher oral health literacy linked to better quality of life in bladder cancer patients! Study of 194 patients reveals dental knowledge impacts treatment outcomes. #BladderCancer #OralHealth #CancerResearch​​​​​​​​​​​​​​​​ www.frontiersin.org/journals/pub...

A question on #BladderCancer #MedicalTreatments tabled by Ms Julie Minns on 18-11-2024 has been answered by Karin Smyth. https://questions-statements.parliament.uk/written-questions/detail/2024-11-18/14793

Day One of #BLADDR24 Dr Maria De Santis MIBC ESMO congress highlights #BladderCancer Perioperative durvalumab to neoadj gemcitabine & cisplatin improves EFS & OS, w/o delays in radical cystectomy @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

Day 1 of #BLADDR24 Dr. Petros Grivas The concept of withholding radical treatment, such as radical cystectomy (RC) or radiotherapy, for patients with a clinical complete response (cCR) after neoadjuvant or induction systemic therapy is emerging as a potential future approach in #BladderCancer MGt

De-intensifying follow ups in low grade NMIBC will certainly help both patients (reduced visits) & clinicians/healthcare economy (reduced costs). However, careful patient selection is key! #bladdercancer #NMIBC #informeddecisionmaking

Perioperative Durvalumab + chemo improves event-free survival and OS in operable bladder cancer. No increase in Grade 3/4 toxicity vs chemo alone. #BladderCancer #Oncology #CancerResearch @oncoalert.bsky.social

☢️💊💉Trimodality therapy offers hope for recurrent T1 bladder cancer after BCG failure! ✅ 3-year freedom from cystectomy: 88% ✅ 3-year OS: 69% 🔷monitoring is key. #BladderCancer #Oncology @oncoalert.bsky.social @oncbrothers.bsky.social @achoud72.bsky.social

The RAIDER findings suggest that DART is a safe and feasible option for #BladderCancer treatment, with the potential for better outcomes. www.icr.ac.uk/news-archive...

A question on #BladderCancer #NewcastleUnderLyme tabled by Adam Jogee on 30-08-2024 has been answered by Karin Smyth. https://questions-statements.parliament.uk/written-questions/detail/2024-08-30/3451

What a great meeting to end the week with the @anzuptrials.bsky.social Masterclass. The ANZUP community came together to brainstorm better ways to improve the outcomes of people suffering #prostatecancer and #bladdercancer. I hope my thoughts on #clinicaltrial simplification were helpful

Day One of #BLADDR24 Dr Eva Maria Compérat Role of AI for diagnosis and monitoring #BladderCancer Emphasizes the broad potential of AI in diagnosing and monitoring @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

Day One of #BLADDR24 Dr Petros Grivas Debate: Role of ctDNA to manage MIBC in the adjuvant setting #BladderCancer Presentation discusses if TOMBOLA is practice changing, and more data is needed @drnataliagandur.bsky.social @barbaramelao.bsky.social @yukselurun.bsky.social @achoud72.bsky.social

... and the SunRise 2 and 4 (TAR-200) results of high T0 response rates reports suggest changes to care. Neither yet published, but shown at #ESMO2024. See www.youtube.com/watch?v=HZK4... and www.targetedonc.com/view/sunrise...

Although self-citing .. the Niagara RCT will change neoadjuvant Rx (albeit maybe briefly) .... www.nejm.org/doi/full/10.... ....

The DaBlaCa-13 Chemoresection study - showing the role of MMC chemo-resection in NMI #bladdercancer ascopubs.org/doi/full/10....

The En Bloc vs. conventional TURBT RCT in @eururoloncol.bsky.social www.sciencedirect.com/science/arti...

I'll start with: SWOG RCT of Lymphadenectomy. Kudos to you all for contributing and completing. Where does it leave any Lymphadenectomy in cystectomy? www.nejm.org/doi/full/10....

To echo @dr-coops.bsky.social i thought we could thread some of the most interesting #BladderCancer papers over the last few months ... that might have missed discussion @alisonbirtle.bsky.social @bladdercancer.bsky.social .....